Differential responses to anxiogenic drugs in a mouse model of panic disorder as revealed by Fos immunocytochemistry in specific areas of the fear circuitry

I. Sahún, X. Gallego, M. Gratacòs, P. Murtra, R. Trullás, R. Maldonado, Xavier P. Estivill, M. Dierssen

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Sensitivity to pharmacological challenges has been reported in patients with panic disorder. We have previously validated transgenic mice overexpressing the neurotrophin-3 (NT-3) receptor, TrkC (TgNTRK3), as an engineered murine model of panic disorder. We could determine that TgNTRK3 mice presented increased cellularity in brain regions, such as the locus ceruleus, that are important neural substrates for the expression of anxiety in severe anxiety states. Here, we investigated the sensitivity to induce anxiety and panic-related symptoms by sodium lactate and the effects of various drugs (the α2-adrenoceptor antagonist, yohimbine and the adenosine antagonist, caffeine), in TgNTRK3 mice. We found enhanced panicogenic sensitivity to sodium lactate and an increased intensity and a differential pattern of Fos expression after the administration of yohimbine or caffeine in TgNTRK3. Our findings validate the relevance of the NT-3/TrkC system to pathological anxiety and raise the possibility that a specific set of fear-related pathways involved in the processing of anxiety-related information may be differentially activated in panic disorder.

Original languageEnglish
Pages (from-to)677-688
Number of pages12
JournalAmino Acids
Volume33
Issue number4
DOIs
Publication statusPublished - Nov 2007
Externally publishedYes

Fingerprint

Sodium Lactate
Yohimbine
Panic Disorder
Caffeine
Fear
trkC Receptor
Anxiety
Immunohistochemistry
Neurotrophin 3
Pharmaceutical Preparations
Adenosine
Adrenergic Receptors
Brain
Substrates
Processing
Panic
Locus Coeruleus
Transgenic Mice
Pharmacology

Keywords

  • Amygdala
  • Caffeine
  • Fos immunohistochemistry
  • Locus ceruleus
  • NT-3
  • Panic disorder
  • TrkC
  • Yohimbine

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Differential responses to anxiogenic drugs in a mouse model of panic disorder as revealed by Fos immunocytochemistry in specific areas of the fear circuitry. / Sahún, I.; Gallego, X.; Gratacòs, M.; Murtra, P.; Trullás, R.; Maldonado, R.; Estivill, Xavier P.; Dierssen, M.

In: Amino Acids, Vol. 33, No. 4, 11.2007, p. 677-688.

Research output: Contribution to journalArticle

Sahún, I. ; Gallego, X. ; Gratacòs, M. ; Murtra, P. ; Trullás, R. ; Maldonado, R. ; Estivill, Xavier P. ; Dierssen, M. / Differential responses to anxiogenic drugs in a mouse model of panic disorder as revealed by Fos immunocytochemistry in specific areas of the fear circuitry. In: Amino Acids. 2007 ; Vol. 33, No. 4. pp. 677-688.
@article{c3744b2a41cb4bb4908abc92a024a03d,
title = "Differential responses to anxiogenic drugs in a mouse model of panic disorder as revealed by Fos immunocytochemistry in specific areas of the fear circuitry",
abstract = "Sensitivity to pharmacological challenges has been reported in patients with panic disorder. We have previously validated transgenic mice overexpressing the neurotrophin-3 (NT-3) receptor, TrkC (TgNTRK3), as an engineered murine model of panic disorder. We could determine that TgNTRK3 mice presented increased cellularity in brain regions, such as the locus ceruleus, that are important neural substrates for the expression of anxiety in severe anxiety states. Here, we investigated the sensitivity to induce anxiety and panic-related symptoms by sodium lactate and the effects of various drugs (the α2-adrenoceptor antagonist, yohimbine and the adenosine antagonist, caffeine), in TgNTRK3 mice. We found enhanced panicogenic sensitivity to sodium lactate and an increased intensity and a differential pattern of Fos expression after the administration of yohimbine or caffeine in TgNTRK3. Our findings validate the relevance of the NT-3/TrkC system to pathological anxiety and raise the possibility that a specific set of fear-related pathways involved in the processing of anxiety-related information may be differentially activated in panic disorder.",
keywords = "Amygdala, Caffeine, Fos immunohistochemistry, Locus ceruleus, NT-3, Panic disorder, TrkC, Yohimbine",
author = "I. Sah{\'u}n and X. Gallego and M. Gratac{\`o}s and P. Murtra and R. Trull{\'a}s and R. Maldonado and Estivill, {Xavier P.} and M. Dierssen",
year = "2007",
month = "11",
doi = "10.1007/s00726-006-0464-1",
language = "English",
volume = "33",
pages = "677--688",
journal = "Amino Acids",
issn = "0939-4451",
publisher = "Springer Wien",
number = "4",

}

TY - JOUR

T1 - Differential responses to anxiogenic drugs in a mouse model of panic disorder as revealed by Fos immunocytochemistry in specific areas of the fear circuitry

AU - Sahún, I.

AU - Gallego, X.

AU - Gratacòs, M.

AU - Murtra, P.

AU - Trullás, R.

AU - Maldonado, R.

AU - Estivill, Xavier P.

AU - Dierssen, M.

PY - 2007/11

Y1 - 2007/11

N2 - Sensitivity to pharmacological challenges has been reported in patients with panic disorder. We have previously validated transgenic mice overexpressing the neurotrophin-3 (NT-3) receptor, TrkC (TgNTRK3), as an engineered murine model of panic disorder. We could determine that TgNTRK3 mice presented increased cellularity in brain regions, such as the locus ceruleus, that are important neural substrates for the expression of anxiety in severe anxiety states. Here, we investigated the sensitivity to induce anxiety and panic-related symptoms by sodium lactate and the effects of various drugs (the α2-adrenoceptor antagonist, yohimbine and the adenosine antagonist, caffeine), in TgNTRK3 mice. We found enhanced panicogenic sensitivity to sodium lactate and an increased intensity and a differential pattern of Fos expression after the administration of yohimbine or caffeine in TgNTRK3. Our findings validate the relevance of the NT-3/TrkC system to pathological anxiety and raise the possibility that a specific set of fear-related pathways involved in the processing of anxiety-related information may be differentially activated in panic disorder.

AB - Sensitivity to pharmacological challenges has been reported in patients with panic disorder. We have previously validated transgenic mice overexpressing the neurotrophin-3 (NT-3) receptor, TrkC (TgNTRK3), as an engineered murine model of panic disorder. We could determine that TgNTRK3 mice presented increased cellularity in brain regions, such as the locus ceruleus, that are important neural substrates for the expression of anxiety in severe anxiety states. Here, we investigated the sensitivity to induce anxiety and panic-related symptoms by sodium lactate and the effects of various drugs (the α2-adrenoceptor antagonist, yohimbine and the adenosine antagonist, caffeine), in TgNTRK3 mice. We found enhanced panicogenic sensitivity to sodium lactate and an increased intensity and a differential pattern of Fos expression after the administration of yohimbine or caffeine in TgNTRK3. Our findings validate the relevance of the NT-3/TrkC system to pathological anxiety and raise the possibility that a specific set of fear-related pathways involved in the processing of anxiety-related information may be differentially activated in panic disorder.

KW - Amygdala

KW - Caffeine

KW - Fos immunohistochemistry

KW - Locus ceruleus

KW - NT-3

KW - Panic disorder

KW - TrkC

KW - Yohimbine

UR - http://www.scopus.com/inward/record.url?scp=33847409033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847409033&partnerID=8YFLogxK

U2 - 10.1007/s00726-006-0464-1

DO - 10.1007/s00726-006-0464-1

M3 - Article

VL - 33

SP - 677

EP - 688

JO - Amino Acids

JF - Amino Acids

SN - 0939-4451

IS - 4

ER -